Prospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Jan 15, 2022; 14(1): 295-318
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.295
Table 1 Baseline characteristics of patients included in this study
Characteristics
Frequency
%
All patients (n = 65)
Age (yr) ± SD73.54 ± 9.51
(range)(52-92)
Gender
Female2944.62
Male3655.38
Tumour localisation
Right colorectal cancer4366.15
   Caecum1330.23
   Ascending colon2353.49
   Transverse colon716.28
Left colorectal cancer2233.85
   Descending colon1150.00
   Sigma 1150.00
Emergency surgery
Yes11.54
No6498.46
Surgical procedure
Laparoscopic hemicolectomy4873.85
Open hemicolectomy1726.15
Development at surgery
Non-metastasised3756.92
Metastases2843.08
   Liver synchronous1346.43
   Liver metachronous828.57
   Other organs1346.43
MMR status
pMMR5686.15
dMMR57.69
Unknown46.15
TNM stage
034.62
I710.77
IIA2132.31
IIB57.69
IIIA23.08
IIIB812.31
IIIC57.69
IV11.54
IVA1015.38
IVB34.62
Adjuvant chemotherapy
Yes3046.15
No3553.85
Blood leukocytes counting (× 103/μL), (normal range)RCRCLCRCP value
White blood cells count (3.6-10.5)7.41 (3.52-16.2)8.19 (4.83-15.8)0.271
   Lymphocytes (1.1-4.5)1.77 (0.46-4.46)2.04 (0.32-4.87)0.235
   Monocytes (0.1-0.9)0.54 (0.20-1.26)0.50 (0.22-1.11)0.493
   Neutrophils (1.5-7.7)4.86 (1.76-15.3)5.34 (2.96-13.0)0.480
   Platelets (150-370)275.65 (101.0-602.0)272.41 (142.0-725.0)0.910
LMRb3.54 (0.42-7.96)4.64 (0.58-11.88)0.046
NLRb3.65 (0.69-25.93)4.61 (0.93-30.66)0.481
PLRb188.58 (52.24-551.22)213.93 (29.16-1187.50)0.585
Table 2 Association of leukocytes counts and ratios with overall and recurrence-free survival
IndexTotal patients
4-year OS

4-year RFS


n (%)
Spearman r
95%CI
P

Spearman r
95%CI
P
LMRb
Right43 (66.2)-0.3039-0.5601 to 0.0053460.0476< 0.05-0.1946-0.4748 to 0.12140.211NS
Left22 (33.8)0.1615-0.2914 to 0.55530.4727NS-0.07447-0.4912 to 0.37000.7419NS
NLRb
Right43 (66.2)0.2262-0.08868 to 0.50000.1446NS0.1062-0.2094 to 0.40170.498NS
Left22 (33.8)-0.06922-0.4872 to 0.37460.7595NS0.1192-0.3305 to 0.52470.5974NS
PLRb
Right43 (66.2)0.2307-0.08405 to 0.50350.1367NS0.06684-0.2470 to 0.36800.6702NS
Left22 (33.8)0.1615-0.2914 to 0.55530.4727NS0.1192-0.3305 to 0.52470.5974NS
CD4t
Right34 (63.0)-0.05561-0.3954 to 0.29760.7548NS0.05447-0.2986 to 0.39440.7596NS
Left20 (37.0)0.01892-0.4387 to 0.46870.9369NS-0.0354-0.4815 to 0.42530.8822NS
CD4pt
Right34 (63.0)0.03708-0.3144 to 0.37960.8351NS0.07371-0.2809 to 0.41060.6787NS
Left20 (37.0)-0.142-0.5597 to 0.33340.5505NS0.3276-0.1483 to 0.68030.1586NS
CD8t
Right34 (63.0)-0.08526-0.4202 to 0.27020.6316NS-0.2083-0.1958 to 0.65310.2372NS
Left20 (37.0)0.03784-0.4233 to 0.48340.8741NS0.2832-0.3863 to 0.30740.2263NS
CD8pt
Right34 (63.0)-0.1186-0.4476 to 0.23860.504NS-0.04486-0.3863 to 0.30740.8011NS
Left20 (37.0)0.3406-0.1340 to 0.68810.1417NS0.3186-0.1581 to 0.67490.171NS
CD4CD8t
Right34 (63.0)-0.1372-0.4626 to 0.22080.4392NS-0.1955-0.5084 to 0.16300.268NS
Left20 (37.0)0.03784-0.4233 to 0.48340.8741NS0.2655-0.2142 to 0.64200.2579NS
CD4CD8pt
Right34 (63.0)-0.07044-0.4079 to 0.28390.6922NS-0.009612-0.3559 to 0.33890.957NS
Left20 (37.0)0.3595-0.1127 to 0.69930.1195NS0.4425-0.01421 to 0.74640.0507NS
CD14t
Right34 (63.0)0.1891-0.1695 to 0.50340.2842NS0.2467-0.1102 to 0.54720.1595NS
Left20 (37.0)0.05677-0.4076 to 0.49780.8121NS-0.1239-0.5470 to 0.34960.6028NS
CD14pt
Right34 (63.0)0.3003-0.05262 to 0.58650.0844NS0.2596-0.09658 to 0.55680.1382NS
Left20 (37.0)0.56770.1533 to 0.81220.009< 0.010.60180.2035 to 0.82920.005< 0.01
LMRt
Right34 (63.0)-0.2929-0.5812 to 0.060700.0927NS-0.4775-0.7075 to -0.15590.0043< 0.01
Left20 (37.0)0.07569-0.3916 to 0.51190.7511NS0.4425-0.01421 to 0.74640.0507NS
LMRpt
Right34 (63.0)-0.4301-0.6764 to -0.097190.0111< 0.05-0.3846-0.6457 to -0.042850.0247< 0.05
Left20 (37.0)0-0.4538 to 0.4538> 0.9999NS-0.0354-0.4815 to 0.42530.8822NS
CD4MRt
Right34 (63.0)-0.2781-0.5704 to 0.076740.1113NS-0.3173-0.5987 to 0.033880.0675NS
Left20 (37.0)0.04736-0.4154 to 0.49070.8428NS0.1949-0.2841 to 0.59600.4102NS
CD4MRpt
Right34 (63.0)-0.2781-0.5704 to 0.076700.1112NS-0.2596-0.5568 to 0.096500.1381NS
Left20 (37.0)-0.473-0.7631 to -0.024450.0352NS-0.0885-0.5214 to 0.38060.7106NS
CD8MRt
Right34 (63.0)-0.2039-0.5149 to 0.15450.2474NS-0.4422-0.6845 to -0.11200.0088< 0.01
Left20 (37.0)0.1135-0.3588 to 0.53960.6337NS0.47790.03071 to 0.76570.0331< 0.05
CD8MRpt
Right34 (63.0)-0.3596-0.6285 to -0.013930.0367< 0.05-0.2788-0.5709 to 0.076010.1104NS
Left20 (37.0)0.1893-0.2894 to 0.59230.4241NS-0.03541-0.4815 to 0.42530.8822NS
LMRb/LMRt
Right34 (63.0)0.1075-0.2492 to 0.43860.545NS0.36210.01678 to 0.63020.0353< 0.05
Left20 (37.0)-0.05677-0.4978 to 0.40760.8121NS-0.4248-0.7366 to 0.035990.0619NS
LMRb/LMRpt
Right34 (63.0)0.241-0.1162 to 0.54300.1698NS0.2884-0.06561 to 0.57790.0981NS
Left20 (37.0)0.1325-0.3420 to 0.55310.5778NS-0.0531-0.4950 to 0.41060.8241NS
LMRb/CD4MRt
Right34 (63.0)0.1372-0.2208 to 0.46260.4392NS0.2467-0.1101 to 0.54730.1595NS
Left20 (37.0)-0.09461-0.5259 to 0.37540.6915NS-0.177-0.5839 to 0.30100.4554NS
LMRb/CD4MRpt
Right34 (63.0)0.1446-0.2136 to 0.46850.4146NS0.189-0.1695 to 0.50340.2843NS
Left20 (37.0)0.45410.0003499 to 0.75280.0443< 0.050.1062-0.3653 to 0.53430.6559NS
LMRb/CD8MRt
Right34 (63.0)0.04078-0.3111 to 0.38280.8189NS0.3364-0.01245 to 0.61230.0517NS
Left20 (37.0)-0.03784-0.4834 to 0.42330.8741NS-0.4071-0.7267 to 0.057350.0748NS
LMRb/CD8MRpt
Right34 (63.0)0.1409-0.2172 to 0.46550.4267NS0.1859-0.1727 to 0.50090.2926NS
Left20 (37.0)-0.1703-0.5794 to 0.30730.4729NS-0.1416-0.5595 to 0.33370.5515NS
Table 3 Univariate and multivariate analyses for prognostic variables of overall survival after surgical interventions of right-sided colorectal cancer and left-sided colorectal cancer
Total patients
Univariate analysis

Multivariate analysis


n (%)
HR
95%CI
P

HR
95%CI
P
VariablesLowHighLowHigh
LMRb
Right34 (63.0)0.5650.3250.9820.043< 0.050.1330.00071.0410.529
Left20 (37.0)1.1410.8671.5020.3461.1410.8671.5020.346
NLRb
Right34 (63.0)1.4161.0191.9670.038< 0.051.4161.0191.9670.038< 0.05
Left20 (37.0)1.0430.9441.1520.4101.1260.9871.2840.078
PLRb
Right34 (63.0)1.0051.0001.0110.0640.9890.7191.3610.946
Left20 (37.0)1.0010.9991.0040.2920.9970.9371.0600.912
CD4t
Right34 (63.0)0.9230.6381.3340.670
Left20 (37.0)0.8430.4931.4390.531
CD4pt
Right34 (63.0)0.9590.8171.1240.604
Left20 (37.0)0.8130.4541.4560.487
CD8t
Right34 (63.0)0.9950.8971.1050.9311.0320.9131.1670.611
Left20 (37.0)0.9540.8601.0570.364
CD8pt
Right34 (63.0)0.7920.6171.0160.0660.8000.6361.0070.058
Left20 (37.0)1.0180.9571.0830.5701.0330.9621.1100.372
CD4CD8t
Right34 (63.0)0.9870.8921.0930.806
Left20 (37.0)0.9370.8331.0540.277
CD4CD8pt
Right34 (63.0)0.8910.7611.0430.1501.0730.8211.4010.606
Left20 (37.0)1.0150.9531.0820.641
CD14t
Right34 (63.0)1.0480.8451.3000.6701.0770.8361.3880.565
Left20 (37.0)0.9790.7031.3620.898
CD14pt
Right34 (63.0)1.1130.8891.3940.3511.3420.9871.8260.060
Left20 (37.0)1.0530.7231.5330.7880.7000.3811.2860.250
LMRt
Right34 (63.0)0.6350.3651.1030.107
Left20 (37.0)1.0000.9081.1010.9970.9760.5551.7160.933
LMRpt
Right34 (63.0)0.4160.1940.8890.024< 0.05
Left20 (37.0)1.0300.7121.4900.8760.0310.0004.2280.166
CD4MRt
Right34 (63.0)0.2700.0391.8500.182
Left20 (37.0)0.7590.1463.9540.743
CD4MRpt
Right34 (63.0)0.4310.1121.6600.221
Left20 (37.0)0.1350.0044.1480.252
CD8MRt
Right34 (63.0)0.7120.3641.3940.321
Left20 (37.0)1.0010.9101.1000.986
CD8MRpt
Right34 (63.0)0.2230.0570.8720.031< 0.050.0240.0010.4300.011< 0.05
Left20 (37.0)1.0780.7751.5000.654
LMRb/LMRt
Right34 (63.0)0.9570.6031.5190.853
Left20 (37.0)1.1630.9351.4460.175
LMRb/LMRpt
Right34 (63.0)1.2530.8241.9070.292
Left20 (37.0)1.1960.8451.6950.313
LMRb/CD4MRt
Right34 (63.0)1.0090.9501.0730.7671.2820.9311.7650.128
Left20 (37.0)1.0270.9611.0990.428
LMRb/CD4MRpt
Right34 (63.0)1.0280.9261.1420.6001.2910.4473.7280.636
Left20 (37.0)1.0971.0111.1900.026< 0.050.9910.4202.3410.984
LMRb/CD8MRt
Right34 (63.0)0.9730.7471.2690.842
Left20 (37.0)1.1030.9401.2940.2291.9710.25815.0690.513
LMRb/CD8MRpt
Right34 (63.0)1.0530.8801.2600.5720.4840.2680.8730.016< 0.05
Left20 (37.0)1.0260.8341.2620.8120.9520.00996.5300.983
Table 4 Univariate and multivariate analyses for prognostic variables of recurrence-free survival after surgical interventions of right-sided colorectal cancer and left-sided colorectal cancer
Total patients
Univariate analysis

Multivariate analysis


n (%)
HR
95%CI
P

HR
95%CI
P

VariablesLowHighLowHigh
LMRb
Right34 (63.0)0.8650.5931.2620.453
Left20 (37.0)0.9770.7701.2390.8480.1560.00124.1180.470
NLRb
Right34 (63.0)1.1350.8411.5320.4072.7601.0507.2540.039< 0.05
Left20 (37.0)1.0941.0941.1800.020< 0.051.1561.0381.2880.009< 0.01
PLRb
Right34 (63.0)1.0010.9961.0070.5960.9780.9580.9990.037< 0.05
Left20 (37.0)1.0021.0001.0040.018< 0.050.9870.9541.0220.468
CD4t
Right34 (63.0)1.0100.8641.1810.9020.8020.4571.4070.441
Left20 (37.0)0.9810.6171.5590.934
CD4pt
Right34 (63.0)0.9630.8511.0910.5561.4860.12417.8280.755
Left20 (37.0)1.1200.7951.5770.516
CD8t
Right34 (63.0)0.9620.8721.0620.4461.8210.4517.3470.400
Left20 (37.0)1.0320.9711.0970.310
CD8pt
Right34 (63.0)0.9060.7801.0530.1991.1170.8481.4720.431
Left20 (37.0)1.0500.9881.1150.1161.0981.0151.1890.020< 0.05
CD4CD8t
Right34 (63.0)0.9720.8931.0580.515
Left20 (37.0)1.0330.9701.1000.3070.4360.1980.9600.039< 0.05
CD4CD8pt
Right34 (63.0)0.9440.8571.0410.248
Left20 (37.0)1.0520.9921.1170.0930.0080.0001.0710.053
CD14t
Right34 (63.0)1.1230.9491.3290.1781.4671.0482.0540.026< 0.05
Left20 (37.0)0.9180.7131.1800.502
CD14pt
Right34 (63.0)1.0750.8911.2970.4491.7900.5925.4060.302
Left20 (37.0)1.4721.0951.9780.010< 0.05
LMRt
Right34 (63.0)0.5550.3370.9150.021< 0.050.6410.2131.9260.428
Left20 (37.0)1.0840.9991.1760.0520.1650.0039.2030.380
LMRpt
Right34 (63.0)0.6910.4581.0420.0780.3120.1230.7930.014< 0.05
Left20 (37.0)1.0660.6881.6530.775
CD4MRt
Right34 (63.0)0.5880.2201.5720.2900.8760.3822.0100.756
Left20 (37.0)0.9500.3812.3700.912
CD4MRpt
Right34 (63.0)0.7340.3271.6480.4547.2290.515101.5440.142
Left20 (37.0)0.5830.1991.7090.325
CD8MRt
Right34 (63.0)0.4970.2461.0050.052
Left20 (37.0)1.0830.9991.1740.0521.1231.0201.2380.019< 0.05
CD8MRpt
Right34 (63.0)0.5840.3331.0230.060
Left20 (37.0)1.1910.8151.7410.3650.2930.0263.3450.323
LMRb/LMRt
Right34 (63.0)1.3111.0131.6970.040< 0.05
Left20 (37.0)0.9580.7301.2580.760
LMRb/LMRpt
Right34 (63.0)1.2480.8871.7560.2030.4040.1690.9690.042< 0.05
Left20 (37.0)1.0300.7871.3470.8301.1320.8591.4930.378
LMRb/CD4MRt
Right34 (63.0)1.0120.9651.0600.6321.0560.9731.1460.192
Left20 (37.0)0.9910.9371.0480.742
LMRb/CD4MRpt
Right34 (63.0)1.0310.9481.1210.4791.3930.8752.2200.163
Left20 (37.0)1.0230.9691.0790.4120.9250.8471.0110.087
LMRb/CD8MRt
Right34 (63.0)1.1461.0171.2920.025< 0.051.3011.0781.5710.006< 0.01
Left20 (37.0)0.9410.7751.1430.5421.0360.5911.8160.903
LMRb/CD8MRpt
Right34 (63.0)1.0220.8941.1690.7461.3900.3046.3500.671
Left20 (37.0)0.9680.8441.1090.6380.8470.5761.2440.397

  • Citation: Cantero-Cid R, Montalbán-Hernández KM, Guevara J, Pascual-Iglesias A, Pulido E, Casalvilla JC, Marcano C, Serrano CB, Valentín J, Bonel-Pérez GC, Avendaño-Ortiz J, Terrón V, Lozano-Rodríguez R, Martín-Quirós A, Marín E, Pena E, Guerra-Pastrián L, López-Collazo E, Aguirre LA. Intertwined leukocyte balances in tumours and peripheral blood as robust predictors of right and left colorectal cancer survival. World J Gastrointest Oncol 2022; 14(1): 295-318
  • URL: https://www.wjgnet.com/1948-5204/full/v14/i1/295.htm
  • DOI: https://dx.doi.org/10.4251/wjgo.v14.i1.295